Related Experiment Video
Updated: May 26, 2026
06:52
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
[Inflammatory bowel diseases and inflammasome]
1Department of Microbiology, Hanyang University College of Medicine, Seoul, Korea. jungmogg@hanyang.ac.kr
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|December 27, 2011
Summary
Inflammasomes, particularly NLRP3, are implicated in inflammatory bowel disease (IBD) pathogenesis by regulating immune responses and cytokine release. Dysregulation of these inflammasomes may offer therapeutic targets for IBD.
Area of Science:
- Gastroenterology and Immunology
- Molecular Biology
- Cellular Biology
Background:
- Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, involves chronic intestinal inflammation due to immune system dysregulation.
- Elevated pro-inflammatory cytokines (e.g., IL-1β, IL-18, TNF-α) correlate with IBD severity, suggesting their critical role.
Purpose of the Study:
- To review recent advances in understanding the role of NLRP3 inflammasome signaling in IBD pathogenesis.
- To explore the potential of inflammasomes as therapeutic targets for IBD.
Main Methods:
- Review of current literature on inflammasome pathways and their involvement in IBD.
- Focus on NLRP3 inflammasome activation, its downstream effects, and its contribution to intestinal inflammation.
Main Results:
- Inflammasomes, including NLRP3, are key regulators of intestinal homeostasis and host defense.
- Activated inflammasomes lead to the release of pro-inflammatory cytokines and pyroptosis, contributing to IBD.
- Dysregulation of inflammasome pathways is increasingly recognized as a factor in IBD development.
Conclusions:
- The NLRP3 inflammasome plays a significant role in the pathogenesis of inflammatory bowel disease.
- Further understanding of inflammasome biology may unveil novel therapeutic strategies for managing IBD.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...